HopeStage
Back to all studies
CompletedNCT00000379

Fluoxetine vs EMDR to Treat PTSD (PTSD)

Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Brookline, United StatesSee all locations and recruitment
Activities
Medication described in the protocol · Behavioural activities described in the protocol
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateJanuary 1999
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Boston University
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00000379
Official title
Show the full official title

Treatment of Outcomes of Fluoxetine vs EMDR in PTSD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Brookline

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston University, a university.

Did this study involve medication?

Yes. The study involved medication, including Fluoxetine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me